Harbour BioMed Announces Submission of IND Application for HBM9378/SKB378 in the Treatment of Chronic Obstructive Pulmonary Disease November 8, 2024 — 17:45
Live from ESMO 2024 | Ascentage Pharma Releases Latest Data Showing Sustained Clinical Efficacy of Olverembatinib in SDH-Deficient GIST during a Mini Oral Presentation September 14, 2024 — 08:18
Transcenta Holding Limited (Stock Code: 6628.HK) Announce 2024 Interim Results August 29, 2024 — 14:31
LAZADA GROUP RELEASES ANNUAL ENVIRONMENTAL, SOCIAL AND GOVERNANCE (ESG) IMPACT REPORT FOR FINANCIAL YEAR 2024 August 27, 2024 — 11:00
Docquity and Vietnam Association of Preventive Medicine (VAPM) Partner to Advance Medical Training August 21, 2024 — 10:00